# NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events

> **NCT04205578** · PHASE3 · UNKNOWN · sponsor: **yuanli Zhao** · enrollment: 450 (estimated)

## Conditions studied

- Moyamoya Disease
- Ischemic Cerebral Infarction
- Ischemic Stroke
- Ischemic Cerebrovascular Accident
- Transient Ischemic Attack

## Interventions

- **DRUG:** dl-3-n-butylphthalide (NBP)
- **DRUG:** Normal Saline 0.9% Infusion Solution

## Key facts

- **NCT ID:** NCT04205578
- **Lead sponsor:** yuanli Zhao
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2019-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04205578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04205578, "NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04205578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*